Zydus Pharmaceuticals (USA) Inc recalls Succinylcholine Chloride…
Zydus Pharmaceuticals (USA) Inc recalls Succinylcholine Chloride Injection
- Published
- 17 Sept 2025
- Units affected
- 270,125 Vials
- Agency
- FDA
- Country
- United States
The hazard
Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL), Rx only, 10 mL Multiple-dose Vial, Sterile, Manufactured by Zydus Lifesciences Ltd, Vadodara, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1377-1 (vial), NDC 70710-1377-2 (carton).
- Brand / company
- Zydus Pharmaceuticals (USA) Inc
- Codes / lots
- Lot #s: L400077, exp: 8/31/2025; L400113, exp.: 9/30/2025; L400372, L400373, exp.: 3/31/2026; L400374, exp.: 4/30/2026.
- Distribution
- MS, OH, LA, and Puerto Rico
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 17 Sept 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.